This is a non-routine insider sale by an officer, but the amount is small relative to market cap. Monitor for actual execution on Form 4 and any pattern of larger insider sales that could signal reduced confidence.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 11 $43.24entry
- T+1 · 5d ago +0.95%α +1.30% · $43.65
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Richard D. Francis, an officer of Teva, filed a Form 144 notice of intent to sell 250,000 ordinary shares, with an estimated aggregate market value of $10,742,500 based on a filing price of approximately $42.97 per share. The shares were acquired through vesting of restricted share units between February 2024 and March 2025 as compensation. The sale is planned for or after November 10, 2026, and represents a notable insider sale relative to the company's $49.7B market cap.
Key Facts
- Insider Richard D. Francis (officer) filed Form 144 to sell 250,000 ordinary shares.
- Estimated aggregate market value of the proposed sale is $10,742,500.
- Shares were acquired through vesting of restricted share units from February 2024 to March 2025.
- The filing date is November 10, 2026; the proposed sale date is also November 10, 2026.
- The sale represents approximately 0.02% of Teva's $49.7B market cap.
- Recent insider activity (30 days) shows 3 sells totaling $3.0M, making this filing a larger single sale.
Financial Impact
Proposed sale of 250,000 shares valued at approximately $10.7M, or about 0.02% of market cap.
Risk Factors
- Form 144 is only an intent to sell; the sale may not be executed.
- The filing does not disclose the officer's remaining holdings, so proportional significance is unclear.
- No context on the company's financial performance or upcoming catalysts is provided in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-455498 |
| Document: 0001193125-26-455498-index.html | 0001193125-26-455498 |
| Document: 0001193125-26-455498.txt | 0001193125-26-455498 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Viewing Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers